NATALIE DUNN: Open Payments
NPI 1194446146 · CHARDON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 57 payments from 18 companies in 2025. Trend: 2023 $396 · 2024 $691 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $313 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Novo Nordisk Inc | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $75 |
| PFIZER INC. | 4 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Lilly USA, LLC | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Lundbeck LLC | 2 | $39 |
| Insmed, Inc. | 2 | $36 |
Products named: UBRELVY, REXULTI, Kerendia, VRAYLAR, NURTEC ODT, CAPLYTA, MOUNJARO, SYNTHROID.
Industry payments across OH — which companies pay providers there.
